Gimv, the Belgian private equity firm listed on Euronext Brussels, has announced it will stop making new life sciences investments. The firm plans to focus instead on growing its Anchor Investments (long-term partnerships with growth companies) and its four main platforms: Consumer, Healthcare, Smart Industries, and Sustainable Cities, which it sees as offering stronger growth potential, especially with ongoing digital changes.
January 28, 2026
